

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 6.66201122 |
| 2 | proteasome assembly (GO:0043248) | 4.83955729 |
| 3 | cytidine deamination (GO:0009972) | 4.74517796 |
| 4 | cytidine metabolic process (GO:0046087) | 4.74517796 |
| 5 | cytidine catabolic process (GO:0006216) | 4.74517796 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.43160456 |
| 7 | DNA deamination (GO:0045006) | 4.36968123 |
| 8 | regulation of response to tumor cell (GO:0002834) | 4.35671186 |
| 9 | positive regulation of response to tumor cell (GO:0002836) | 4.35671186 |
| 10 | positive regulation of immune response to tumor cell (GO:0002839) | 4.35671186 |
| 11 | regulation of immune response to tumor cell (GO:0002837) | 4.35671186 |
| 12 | cullin deneddylation (GO:0010388) | 4.11096569 |
| 13 | lactate metabolic process (GO:0006089) | 4.04200913 |
| 14 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.99432781 |
| 15 | rRNA methylation (GO:0031167) | 3.96127054 |
| 16 | protein deneddylation (GO:0000338) | 3.91235428 |
| 17 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.72551644 |
| 18 | rRNA modification (GO:0000154) | 3.59284272 |
| 19 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.31711214 |
| 20 | positive regulation of T cell cytokine production (GO:0002726) | 3.16590838 |
| 21 | protein maturation by protein folding (GO:0022417) | 3.16418256 |
| 22 | regulation of translational termination (GO:0006449) | 3.11867159 |
| 23 | interferon-gamma production (GO:0032609) | 3.10496154 |
| 24 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.06943744 |
| 25 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.04807776 |
| 26 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.03513030 |
| 27 | autophagic vacuole fusion (GO:0000046) | 3.02645989 |
| 28 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.00883419 |
| 29 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.00207508 |
| 30 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.99206097 |
| 31 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.97301512 |
| 32 | organelle membrane fusion (GO:0090174) | 2.97295262 |
| 33 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.96031480 |
| 34 | pseudouridine synthesis (GO:0001522) | 2.95516179 |
| 35 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.93896849 |
| 36 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.92668325 |
| 37 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.92053720 |
| 38 | regulation of T cell chemotaxis (GO:0010819) | 2.91418328 |
| 39 | positive regulation of T cell chemotaxis (GO:0010820) | 2.91418328 |
| 40 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.91056597 |
| 41 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.91056597 |
| 42 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.91056597 |
| 43 | ribosome assembly (GO:0042255) | 2.90908367 |
| 44 | regulation of meiosis I (GO:0060631) | 2.90633095 |
| 45 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.90583111 |
| 46 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.90583111 |
| 47 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.90439048 |
| 48 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.86511856 |
| 49 | negative regulation of ligase activity (GO:0051352) | 2.86511856 |
| 50 | nucleobase biosynthetic process (GO:0046112) | 2.83793222 |
| 51 | positive regulation of granulocyte differentiation (GO:0030854) | 2.79956731 |
| 52 | regulation of translation in response to stress (GO:0043555) | 2.79415800 |
| 53 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.79385047 |
| 54 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.79385047 |
| 55 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.78944779 |
| 56 | DNA double-strand break processing (GO:0000729) | 2.78326820 |
| 57 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.75734200 |
| 58 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.75652128 |
| 59 | branched-chain amino acid catabolic process (GO:0009083) | 2.75562989 |
| 60 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.74457716 |
| 61 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.74334847 |
| 62 | phospholipid homeostasis (GO:0055091) | 2.70872285 |
| 63 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.69391646 |
| 64 | heparin metabolic process (GO:0030202) | 2.68055487 |
| 65 | heparin biosynthetic process (GO:0030210) | 2.68055487 |
| 66 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.62834097 |
| 67 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.62631516 |
| 68 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.62631516 |
| 69 | isotype switching (GO:0045190) | 2.62631516 |
| 70 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.60014861 |
| 71 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.59274174 |
| 72 | purine nucleobase biosynthetic process (GO:0009113) | 2.57079569 |
| 73 | positive regulation of ligase activity (GO:0051351) | 2.56058933 |
| 74 | negative regulation of T cell apoptotic process (GO:0070233) | 2.55780731 |
| 75 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.54916924 |
| 76 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.53647051 |
| 77 | positive regulation of cell cycle arrest (GO:0071158) | 2.52195237 |
| 78 | 7-methylguanosine mRNA capping (GO:0006370) | 2.51674147 |
| 79 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.50735507 |
| 80 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.47116657 |
| 81 | NADPH regeneration (GO:0006740) | 2.46266523 |
| 82 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.44984532 |
| 83 | positive regulation of cell killing (GO:0031343) | 2.44195078 |
| 84 | positive regulation of DNA recombination (GO:0045911) | 2.43519952 |
| 85 | 7-methylguanosine RNA capping (GO:0009452) | 2.43212570 |
| 86 | RNA capping (GO:0036260) | 2.43212570 |
| 87 | branched-chain amino acid metabolic process (GO:0009081) | 2.41899025 |
| 88 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.41381472 |
| 89 | high-density lipoprotein particle remodeling (GO:0034375) | 2.40847904 |
| 90 | termination of RNA polymerase III transcription (GO:0006386) | 2.40764548 |
| 91 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.40764548 |
| 92 | hepatocyte apoptotic process (GO:0097284) | 2.38911108 |
| 93 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.38391249 |
| 94 | inner mitochondrial membrane organization (GO:0007007) | 2.37482474 |
| 95 | regulation of RIG-I signaling pathway (GO:0039535) | 2.37426232 |
| 96 | response to pheromone (GO:0019236) | 2.37179472 |
| 97 | NIK/NF-kappaB signaling (GO:0038061) | 2.35883301 |
| 98 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.35205255 |
| 99 | positive regulation of macrophage differentiation (GO:0045651) | 2.35116235 |
| 100 | regulation of ligase activity (GO:0051340) | 2.34946499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.60477327 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.39104534 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.35810530 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.19869605 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.75641692 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.74321281 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.72414269 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.69794681 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.61236086 |
| 10 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.58771139 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.52775879 |
| 12 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.41880644 |
| 13 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.40567251 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.38638233 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.38026089 |
| 16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.37191247 |
| 17 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.34953500 |
| 18 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.24774090 |
| 19 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.20478671 |
| 20 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.10273768 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.06693078 |
| 22 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.98797919 |
| 23 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.94584040 |
| 24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.88971717 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.88471556 |
| 26 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.87964426 |
| 27 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.85976299 |
| 28 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.80245818 |
| 29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.78943800 |
| 30 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.75479066 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74200179 |
| 32 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.69208224 |
| 33 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.68786523 |
| 34 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.66931480 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66815141 |
| 36 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.65481044 |
| 37 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.64419986 |
| 38 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.63151768 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.60732739 |
| 40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.59975555 |
| 41 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.58771963 |
| 42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57371913 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.57273541 |
| 44 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.57240653 |
| 45 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.50425859 |
| 46 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.47401692 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.47350798 |
| 48 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.47313680 |
| 49 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.46493081 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44793817 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43205968 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41558268 |
| 53 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.40581259 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39121552 |
| 55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37485278 |
| 56 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.32945982 |
| 57 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.31671823 |
| 58 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.31258086 |
| 59 | MYB_26560356_Chip-Seq_TH1_Human | 1.31086235 |
| 60 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.30570281 |
| 61 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.28398899 |
| 62 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.28029509 |
| 63 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27279531 |
| 64 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.27142932 |
| 65 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.26370513 |
| 66 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.22705587 |
| 67 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.21481668 |
| 68 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.18976680 |
| 69 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.18130373 |
| 70 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17959608 |
| 71 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.15876622 |
| 72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.15330034 |
| 73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.15000101 |
| 74 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.11600854 |
| 75 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.07337069 |
| 76 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06667836 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05961819 |
| 78 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05060988 |
| 79 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04684476 |
| 80 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02039538 |
| 81 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01666011 |
| 82 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01269122 |
| 83 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.00135589 |
| 84 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.97027573 |
| 85 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96813131 |
| 86 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.93823026 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93699591 |
| 88 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92370710 |
| 89 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91418693 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89332812 |
| 91 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.88573012 |
| 92 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.88273120 |
| 93 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.87412317 |
| 94 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.87199367 |
| 95 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.87072028 |
| 96 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86701760 |
| 97 | GATA3_26560356_Chip-Seq_TH1_Human | 0.86444921 |
| 98 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.83414309 |
| 99 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.82918294 |
| 100 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.82000921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000372_irregular_coat_pigmentation | 4.42894980 |
| 2 | MP0003950_abnormal_plasma_membrane | 3.41945848 |
| 3 | MP0008058_abnormal_DNA_repair | 3.10867900 |
| 4 | MP0005464_abnormal_platelet_physiology | 3.01841708 |
| 5 | MP0005451_abnormal_body_composition | 2.86833364 |
| 6 | MP0003786_premature_aging | 2.70766523 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.69345158 |
| 8 | MP0009840_abnormal_foam_cell | 2.61152145 |
| 9 | MP0005671_abnormal_response_to | 2.58254939 |
| 10 | MP0009333_abnormal_splenocyte_physiolog | 2.49634646 |
| 11 | MP0005075_abnormal_melanosome_morpholog | 2.40047696 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.22369152 |
| 13 | MP0003111_abnormal_nucleus_morphology | 2.15425541 |
| 14 | MP0010094_abnormal_chromosome_stability | 2.12345755 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.12128047 |
| 16 | MP0009785_altered_susceptibility_to | 2.08628870 |
| 17 | MP0000015_abnormal_ear_pigmentation | 2.01485327 |
| 18 | MP0002396_abnormal_hematopoietic_system | 1.98942294 |
| 19 | MP0008007_abnormal_cellular_replicative | 1.89108711 |
| 20 | MP0002102_abnormal_ear_morphology | 1.84829522 |
| 21 | MP0005645_abnormal_hypothalamus_physiol | 1.79986453 |
| 22 | MP0003718_maternal_effect | 1.73836201 |
| 23 | MP0005000_abnormal_immune_tolerance | 1.69393037 |
| 24 | MP0004147_increased_porphyrin_level | 1.68658208 |
| 25 | MP0006036_abnormal_mitochondrial_physio | 1.66416152 |
| 26 | MP0006054_spinal_hemorrhage | 1.64829105 |
| 27 | MP0009697_abnormal_copulation | 1.62416987 |
| 28 | MP0004957_abnormal_blastocyst_morpholog | 1.57264211 |
| 29 | MP0002398_abnormal_bone_marrow | 1.51319695 |
| 30 | MP0001661_extended_life_span | 1.50795685 |
| 31 | MP0005408_hypopigmentation | 1.50713457 |
| 32 | MP0002006_tumorigenesis | 1.44262891 |
| 33 | MP0003077_abnormal_cell_cycle | 1.43045863 |
| 34 | MP0008995_early_reproductive_senescence | 1.41206932 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.38816119 |
| 36 | MP0000703_abnormal_thymus_morphology | 1.36121871 |
| 37 | MP0000685_abnormal_immune_system | 1.36083000 |
| 38 | MP0000358_abnormal_cell_content/ | 1.33922359 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.30970092 |
| 40 | MP0008872_abnormal_physiological_respon | 1.30656087 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.30384596 |
| 42 | MP0002722_abnormal_immune_system | 1.28553939 |
| 43 | MP0003283_abnormal_digestive_organ | 1.28390630 |
| 44 | MP0002420_abnormal_adaptive_immunity | 1.23124237 |
| 45 | MP0001819_abnormal_immune_cell | 1.20341684 |
| 46 | MP0002163_abnormal_gland_morphology | 1.18040986 |
| 47 | MP0002723_abnormal_immune_serum | 1.15720095 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.15112503 |
| 49 | MP0003693_abnormal_embryo_hatching | 1.14508711 |
| 50 | MP0005257_abnormal_intraocular_pressure | 1.14083610 |
| 51 | MP0005410_abnormal_fertilization | 1.13636766 |
| 52 | MP0000716_abnormal_immune_system | 1.12400833 |
| 53 | MP0002019_abnormal_tumor_incidence | 1.12342007 |
| 54 | MP0002429_abnormal_blood_cell | 1.12149315 |
| 55 | MP0004381_abnormal_hair_follicle | 1.11788944 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.11694145 |
| 57 | MP0010352_gastrointestinal_tract_polyps | 1.11683364 |
| 58 | MP0002234_abnormal_pharynx_morphology | 1.11262073 |
| 59 | MP0001529_abnormal_vocalization | 1.10177067 |
| 60 | MP0005310_abnormal_salivary_gland | 1.05286718 |
| 61 | MP0000013_abnormal_adipose_tissue | 1.04841098 |
| 62 | MP0003448_altered_tumor_morphology | 1.03896774 |
| 63 | MP0008260_abnormal_autophagy | 1.03319287 |
| 64 | MP0005025_abnormal_response_to | 1.01615323 |
| 65 | MP0003866_abnormal_defecation | 1.00964937 |
| 66 | MP0002693_abnormal_pancreas_physiology | 0.97984081 |
| 67 | MP0001800_abnormal_humoral_immune | 0.97937403 |
| 68 | MP0002452_abnormal_antigen_presenting | 0.97697911 |
| 69 | MP0001929_abnormal_gametogenesis | 0.97431629 |
| 70 | MP0001666_abnormal_nutrient_absorption | 0.96585134 |
| 71 | MP0006082_CNS_inflammation | 0.93175325 |
| 72 | MP0001845_abnormal_inflammatory_respons | 0.91594786 |
| 73 | MP0010307_abnormal_tumor_latency | 0.90209478 |
| 74 | MP0000371_diluted_coat_color | 0.89570320 |
| 75 | MP0010329_abnormal_lipoprotein_level | 0.87597715 |
| 76 | MP0005220_abnormal_exocrine_pancreas | 0.86695601 |
| 77 | MP0002736_abnormal_nociception_after | 0.86317380 |
| 78 | MP0008057_abnormal_DNA_replication | 0.85645364 |
| 79 | MP0002876_abnormal_thyroid_physiology | 0.84969854 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.84816490 |
| 81 | MP0006035_abnormal_mitochondrial_morpho | 0.84034828 |
| 82 | MP0008873_increased_physiological_sensi | 0.83106152 |
| 83 | MP0001790_abnormal_immune_system | 0.82487631 |
| 84 | MP0005387_immune_system_phenotype | 0.82487631 |
| 85 | MP0001119_abnormal_female_reproductive | 0.82211752 |
| 86 | MP0000313_abnormal_cell_death | 0.81237616 |
| 87 | MP0005253_abnormal_eye_physiology | 0.80126128 |
| 88 | MP0000490_abnormal_crypts_of | 0.79506926 |
| 89 | MP0008469_abnormal_protein_level | 0.79471325 |
| 90 | MP0009763_increased_sensitivity_to | 0.78888422 |
| 91 | MP0003186_abnormal_redox_activity | 0.76514115 |
| 92 | MP0000858_altered_metastatic_potential | 0.76183360 |
| 93 | MP0001764_abnormal_homeostasis | 0.76080190 |
| 94 | MP0001730_embryonic_growth_arrest | 0.74441689 |
| 95 | MP0002405_respiratory_system_inflammati | 0.73144069 |
| 96 | MP0003436_decreased_susceptibility_to | 0.72018690 |
| 97 | MP0008932_abnormal_embryonic_tissue | 0.71904534 |
| 98 | MP0002095_abnormal_skin_pigmentation | 0.69009851 |
| 99 | MP0005379_endocrine/exocrine_gland_phen | 0.68697605 |
| 100 | MP0003943_abnormal_hepatobiliary_system | 0.68230517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Optic neuritis (HP:0100653) | 4.99874268 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 4.99874268 |
| 3 | Orchitis (HP:0100796) | 4.04929050 |
| 4 | Abnormal pupillary function (HP:0007686) | 3.93501701 |
| 5 | Autoimmune hemolytic anemia (HP:0001890) | 3.85454083 |
| 6 | 3-Methylglutaconic aciduria (HP:0003535) | 3.80562369 |
| 7 | Myositis (HP:0100614) | 3.48172684 |
| 8 | Petechiae (HP:0000967) | 3.46519897 |
| 9 | Keratoconjunctivitis sicca (HP:0001097) | 3.28069252 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.26997529 |
| 11 | Joint swelling (HP:0001386) | 3.25260377 |
| 12 | Upper limb muscle weakness (HP:0003484) | 3.22725564 |
| 13 | Keratoconjunctivitis (HP:0001096) | 3.20018646 |
| 14 | Abnormality of T cells (HP:0002843) | 3.12219351 |
| 15 | Abnormal gallbladder physiology (HP:0012438) | 3.10106333 |
| 16 | Cholecystitis (HP:0001082) | 3.10106333 |
| 17 | Encephalitis (HP:0002383) | 3.05083493 |
| 18 | Abnormality of T cell physiology (HP:0011840) | 2.94039523 |
| 19 | Abnormality of the anterior horn cell (HP:0006802) | 2.92882250 |
| 20 | Degeneration of anterior horn cells (HP:0002398) | 2.92882250 |
| 21 | Abnormality of T cell number (HP:0011839) | 2.88920751 |
| 22 | Abnormality of the pons (HP:0007361) | 2.84719873 |
| 23 | Cutaneous melanoma (HP:0012056) | 2.82831852 |
| 24 | T lymphocytopenia (HP:0005403) | 2.82246549 |
| 25 | Eosinophilia (HP:0001880) | 2.81187374 |
| 26 | Tetraparesis (HP:0002273) | 2.73865003 |
| 27 | Chronic hepatic failure (HP:0100626) | 2.72150515 |
| 28 | Tongue fasciculations (HP:0001308) | 2.68395159 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 2.65444304 |
| 30 | Granulocytopenia (HP:0001913) | 2.64350721 |
| 31 | Acute encephalopathy (HP:0006846) | 2.61825994 |
| 32 | Hypoproteinemia (HP:0003075) | 2.57405237 |
| 33 | Prolonged bleeding time (HP:0003010) | 2.56597057 |
| 34 | Increased CSF lactate (HP:0002490) | 2.50169598 |
| 35 | Type I transferrin isoform profile (HP:0003642) | 2.48033636 |
| 36 | Acute necrotizing encephalopathy (HP:0006965) | 2.46208323 |
| 37 | Abnormality of eosinophils (HP:0001879) | 2.44458186 |
| 38 | Arterial thrombosis (HP:0004420) | 2.41246831 |
| 39 | Hyperlipoproteinemia (HP:0010980) | 2.40991107 |
| 40 | Menorrhagia (HP:0000132) | 2.40366287 |
| 41 | IgG deficiency (HP:0004315) | 2.37753282 |
| 42 | Hepatosplenomegaly (HP:0001433) | 2.36334355 |
| 43 | Dyschromatopsia (HP:0007641) | 2.33798705 |
| 44 | Increased serum lactate (HP:0002151) | 2.33434205 |
| 45 | Hypothermia (HP:0002045) | 2.27882852 |
| 46 | Progressive muscle weakness (HP:0003323) | 2.27620127 |
| 47 | Anorexia (HP:0002039) | 2.26381375 |
| 48 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.24906549 |
| 49 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.24906549 |
| 50 | Chronic diarrhea (HP:0002028) | 2.24835670 |
| 51 | Premature ovarian failure (HP:0008209) | 2.24214525 |
| 52 | Polyneuropathy (HP:0001271) | 2.23958887 |
| 53 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.22377217 |
| 54 | Pulmonary infiltrates (HP:0002113) | 2.20864166 |
| 55 | Muscle fibrillation (HP:0010546) | 2.16592313 |
| 56 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.13502289 |
| 57 | IgA deficiency (HP:0002720) | 2.12831316 |
| 58 | Acute hepatic failure (HP:0006554) | 2.10625244 |
| 59 | Epistaxis (HP:0000421) | 2.09102345 |
| 60 | Abnormality of lateral ventricle (HP:0030047) | 2.02802165 |
| 61 | Generalized aminoaciduria (HP:0002909) | 2.02127369 |
| 62 | Progressive macrocephaly (HP:0004481) | 2.00994358 |
| 63 | Hepatocellular necrosis (HP:0001404) | 1.98822200 |
| 64 | Popliteal pterygium (HP:0009756) | 1.96929744 |
| 65 | Squamous cell carcinoma (HP:0002860) | 1.96362254 |
| 66 | Mitochondrial inheritance (HP:0001427) | 1.92848533 |
| 67 | Nausea (HP:0002018) | 1.90023416 |
| 68 | Increased IgM level (HP:0003496) | 1.88426634 |
| 69 | Increased mean platelet volume (HP:0011877) | 1.87217135 |
| 70 | Fatigue (HP:0012378) | 1.87004765 |
| 71 | Gangrene (HP:0100758) | 1.84685254 |
| 72 | Cerebral hypomyelination (HP:0006808) | 1.84566566 |
| 73 | Hypoplasia of the pons (HP:0012110) | 1.81764322 |
| 74 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.81627174 |
| 75 | Severe combined immunodeficiency (HP:0004430) | 1.81530434 |
| 76 | Abnormal platelet volume (HP:0011876) | 1.80659695 |
| 77 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.79949297 |
| 78 | Hypoplasia of the fovea (HP:0007750) | 1.79949297 |
| 79 | Late onset (HP:0003584) | 1.75100263 |
| 80 | Autoimmune thrombocytopenia (HP:0001973) | 1.75017662 |
| 81 | Abnormal protein glycosylation (HP:0012346) | 1.74479930 |
| 82 | Abnormal glycosylation (HP:0012345) | 1.74479930 |
| 83 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.74479930 |
| 84 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.74479930 |
| 85 | Glomerulopathy (HP:0100820) | 1.73993010 |
| 86 | Hepatic necrosis (HP:0002605) | 1.73661349 |
| 87 | Horizontal nystagmus (HP:0000666) | 1.73036914 |
| 88 | Progressive external ophthalmoplegia (HP:0000590) | 1.72425713 |
| 89 | Volvulus (HP:0002580) | 1.71954311 |
| 90 | Lactic acidosis (HP:0003128) | 1.71573259 |
| 91 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.71426845 |
| 92 | Long clavicles (HP:0000890) | 1.70644379 |
| 93 | Aplastic anemia (HP:0001915) | 1.70540627 |
| 94 | Nonimmune hydrops fetalis (HP:0001790) | 1.69370394 |
| 95 | Optic disc pallor (HP:0000543) | 1.68430584 |
| 96 | Purpura (HP:0000979) | 1.68061609 |
| 97 | CNS hypomyelination (HP:0003429) | 1.66717443 |
| 98 | Disproportionate short-trunk short stature (HP:0003521) | 1.66691609 |
| 99 | Loss of speech (HP:0002371) | 1.66086711 |
| 100 | Easy fatigability (HP:0003388) | 1.65136964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 4.88407376 |
| 2 | EIF2AK3 | 4.64099412 |
| 3 | EIF2AK1 | 3.81716752 |
| 4 | BUB1 | 3.50128865 |
| 5 | MAP2K6 | 2.96592224 |
| 6 | TRIM28 | 2.83161813 |
| 7 | TXK | 2.73967769 |
| 8 | MAP4K2 | 2.65350745 |
| 9 | TAOK3 | 2.48320697 |
| 10 | TSSK6 | 2.37168883 |
| 11 | IRAK3 | 2.35917682 |
| 12 | CLK1 | 2.13975665 |
| 13 | SRPK1 | 2.00626926 |
| 14 | MAP4K1 | 1.97007626 |
| 15 | BCKDK | 1.77443663 |
| 16 | ZAK | 1.67034590 |
| 17 | PLK3 | 1.58427969 |
| 18 | CDK8 | 1.39289957 |
| 19 | BMPR1B | 1.38518184 |
| 20 | MAP3K14 | 1.38406194 |
| 21 | KDR | 1.36795070 |
| 22 | NEK1 | 1.34706175 |
| 23 | TGFBR2 | 1.33218715 |
| 24 | PLK2 | 1.30881999 |
| 25 | MKNK2 | 1.30450053 |
| 26 | BCR | 1.26829946 |
| 27 | MAP3K12 | 1.24877748 |
| 28 | NUAK1 | 1.22299616 |
| 29 | ITK | 1.22121051 |
| 30 | STK3 | 1.18334004 |
| 31 | STK16 | 1.17675379 |
| 32 | WEE1 | 1.14300709 |
| 33 | JAK3 | 1.13927539 |
| 34 | SIK3 | 1.13329744 |
| 35 | TNK2 | 1.11604907 |
| 36 | BRSK2 | 1.09892782 |
| 37 | TLK1 | 1.09548242 |
| 38 | PDK2 | 1.07894814 |
| 39 | VRK2 | 1.05945068 |
| 40 | FGFR4 | 1.05627120 |
| 41 | TESK2 | 0.97982433 |
| 42 | GRK1 | 0.95347802 |
| 43 | FGFR1 | 0.93750386 |
| 44 | EIF2AK2 | 0.85971773 |
| 45 | NEK9 | 0.85420158 |
| 46 | PBK | 0.85398146 |
| 47 | MUSK | 0.83985778 |
| 48 | LIMK1 | 0.82611532 |
| 49 | MYLK | 0.81255391 |
| 50 | TYK2 | 0.75822527 |
| 51 | TTK | 0.75642846 |
| 52 | PRKCQ | 0.75054692 |
| 53 | VRK1 | 0.74483249 |
| 54 | MAPK11 | 0.73716128 |
| 55 | FRK | 0.73017386 |
| 56 | STK4 | 0.72057053 |
| 57 | MKNK1 | 0.71920443 |
| 58 | ILK | 0.71236316 |
| 59 | FER | 0.68827958 |
| 60 | PRKCI | 0.67599267 |
| 61 | MAPKAPK3 | 0.66963885 |
| 62 | PRKCH | 0.66178916 |
| 63 | ATR | 0.64750371 |
| 64 | PNCK | 0.64353220 |
| 65 | CDK7 | 0.62292133 |
| 66 | CSF1R | 0.61664309 |
| 67 | PLK1 | 0.61594204 |
| 68 | SYK | 0.60774376 |
| 69 | PAK3 | 0.60166643 |
| 70 | STK10 | 0.57200879 |
| 71 | ALK | 0.56326030 |
| 72 | PIM2 | 0.55578368 |
| 73 | WNK4 | 0.53784892 |
| 74 | DAPK1 | 0.53403357 |
| 75 | BMX | 0.51603146 |
| 76 | JAK1 | 0.47939099 |
| 77 | PAK4 | 0.47504392 |
| 78 | PAK1 | 0.44850361 |
| 79 | CAMKK2 | 0.44637176 |
| 80 | NME2 | 0.43271248 |
| 81 | BRSK1 | 0.41353928 |
| 82 | TGFBR1 | 0.40747019 |
| 83 | BTK | 0.40520215 |
| 84 | CSNK1G3 | 0.38249558 |
| 85 | ACVR1B | 0.38149104 |
| 86 | PTK2B | 0.37214745 |
| 87 | CHEK1 | 0.37149785 |
| 88 | ERBB3 | 0.36865098 |
| 89 | CHEK2 | 0.35462253 |
| 90 | TEC | 0.34859249 |
| 91 | FLT3 | 0.34421885 |
| 92 | TBK1 | 0.33218040 |
| 93 | LCK | 0.33096284 |
| 94 | CSNK1A1L | 0.31814088 |
| 95 | ATM | 0.31416637 |
| 96 | FGFR3 | 0.30802763 |
| 97 | MARK3 | 0.30383351 |
| 98 | CSNK1G1 | 0.28470977 |
| 99 | KIT | 0.28319356 |
| 100 | IKBKB | 0.28187563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.28144882 |
| 2 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.81991585 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.81752617 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.77732703 |
| 5 | Basal transcription factors_Homo sapiens_hsa03022 | 2.44422962 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.38632508 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.25028509 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.23770200 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.22377195 |
| 10 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.18860386 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.11118714 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.09892856 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.99220617 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.89904379 |
| 15 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.85733818 |
| 16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.84155418 |
| 17 | DNA replication_Homo sapiens_hsa03030 | 1.81631866 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.81504898 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.81287722 |
| 20 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.78897468 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.69930537 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.66083102 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.65904066 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.64557870 |
| 25 | RNA transport_Homo sapiens_hsa03013 | 1.61681279 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56490331 |
| 27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.55194591 |
| 28 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.50273455 |
| 29 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.48054975 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.47083709 |
| 31 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.42481282 |
| 32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.32045476 |
| 33 | Base excision repair_Homo sapiens_hsa03410 | 1.30780372 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.30514960 |
| 35 | Measles_Homo sapiens_hsa05162 | 1.27676708 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21183217 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.20554539 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14877069 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14428604 |
| 40 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.13461179 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10499689 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04391960 |
| 43 | Spliceosome_Homo sapiens_hsa03040 | 1.02819817 |
| 44 | Cell cycle_Homo sapiens_hsa04110 | 1.01566637 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.98776267 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98090081 |
| 47 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.97429404 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96142384 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.93692917 |
| 50 | RNA degradation_Homo sapiens_hsa03018 | 0.92171059 |
| 51 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91205706 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.88142424 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86538992 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85786461 |
| 55 | Allograft rejection_Homo sapiens_hsa05330 | 0.84653950 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84375220 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.83411660 |
| 58 | Purine metabolism_Homo sapiens_hsa00230 | 0.83358337 |
| 59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83305534 |
| 60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76272718 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75957873 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.75838190 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75179817 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74302028 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72568093 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.72430418 |
| 67 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.71099657 |
| 68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70487537 |
| 69 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.64413093 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64293657 |
| 71 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.61726849 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60450940 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59498708 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58984161 |
| 75 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.58809658 |
| 76 | Apoptosis_Homo sapiens_hsa04210 | 0.56860379 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55536307 |
| 78 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.55264806 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53465830 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52359091 |
| 81 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51639025 |
| 82 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51098621 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50964075 |
| 84 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.49578862 |
| 85 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49416898 |
| 86 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48373952 |
| 87 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.44479639 |
| 88 | Parkinsons disease_Homo sapiens_hsa05012 | 0.42781837 |
| 89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42154289 |
| 90 | Hepatitis B_Homo sapiens_hsa05161 | 0.41960688 |
| 91 | Phototransduction_Homo sapiens_hsa04744 | 0.41515332 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39738322 |
| 93 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37563986 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35085062 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30404511 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30199404 |
| 97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29817708 |
| 98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29486812 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29329269 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29306836 |

